Vanadate and cardiac glycosides.
D002301:Cardiac Glycosides / Q000009:adverse effects*; D004347:Drug Interactions; D006801:Humans; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors; D014638:Vanadates; D014639:Vanadium / Q000009:adverse effects*
D002301:Cardiac Glycosides; D014639:Vanadium; D014638:Vanadates; D000254:Sodium-Potassium-Exchanging ATPase